Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Globus MedicalGMED -4.83%96 Buyback Yield % is 1.05 as of Jul. 19, 2026, which is 425% above its 10-year median of 0.20. GuruFocus rates GMED with a GF Score™ of 96/100 and a GF Value™ of $98.79 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 348 Medical Devices & Instruments companies, Globus Medical ranks better than 80.75% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Globus Medical's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GMED vs PEN, PODD, BRKR: Buyback Yield % Comparison
For the Medical Devices subindustry, Globus Medical's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Globus Medical's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical (GMED) has a Buyback Yield % of 1.05 as of Jul. 19, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Globus Medical and its competitors. This is 425% above median its historical median of 0.20. According to the industry distribution chart, Globus Medical ranks #67 out of 348 companies in the Medical Devices & Instruments industry, placing it in the top 19.3%.
Is Globus Medical's Buyback Yield % too high?
Globus Medical's current Buyback Yield % of 1.05 is 425% above median its 10-year median of 0.20. Based on the distribution chart, Globus Medical ranks #67 out of 348 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Buyback Yield % compare to PEN and PODD?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #67 out of 348 companies for Buyback Yield %. This places Globus Medical in the top 19% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Globus Medical and its competitors. Globus Medical's current Buyback Yield % is 1.05, which is 425% above median its own 10-year median of 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.79, compared to a current price of $77.00 — trading 22.1% below its estimated fair value. The current Buyback Yield % is 1.05, which is 425% above median its 10-year median of 0.20. Globus Medical's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Globus Medical (GMED), the current Buyback Yield % is 1.05 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of $77.00 is trading 22.1% below its estimated GF Value™ of $98.79.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for GMED:
Buyback Yield %: 1.05 (425% above median its 10-year median of 0.20)
GF Value™: $98.79 vs. price of $77.00 (22.1% below fair value)
No single metric tells the full story. See the GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
96GF Score
Get the complete analysis for GMED
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GMED has been successfully added to your 
